Japanese Phase I of GSK1605786

NCT01611805 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: GSK1605786
DRUG: GSK1605786 Placebo

Sponsor

GlaxoSmithKline